Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2014

Open Access 01-12-2014 | Research Article

The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin’s lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study

Authors: Clare Meernik, Amr S Soliman, Twalib Ngoma, Crispin Kahesa, Julius Mwaiselage, Sofia D Merajver

Published in: Infectious Agents and Cancer | Issue 1/2014

Login to get access

Abstract

Background

In Tanzania, 5.1% of adults aged 15-49 are infected with HIV. While rates of HIV-related malignancies have declined globally with antiretroviral therapy (ART), including Tanzania, rates of non-AIDS-defining cancers (NADCs) are believed to have increased. Therefore, we determined trends of three NADCs in Tanzania: ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin’s lymphoma.

Methods

This study was conducted at the Ocean Road Cancer Institute (ORCI) in Dar es Salaam. All medical records of patients diagnosed with ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin’s lymphoma between 2002 and 2012 were reviewed regarding HIV status, cancer clinical characteristics and management. Analysis was conducted to determine trends and proportions in these three NADCs and patient characteristics.

Results

We identified 980 NADCs. The relative proportion of these three NADCs at ORCI out of all cancers treated increased from 2.37% in 2002 to a peak of 4.34% in 2009. The prevalence of HIV in patients diagnosed with these NADCs also increased—from 6.67% in 2002 to 20.87% in 2010—and 85% of squamous cell carcinoma of the eye cancer patients with a reported HIV status were HIV-positive.

Conclusions

The frequency and proportions of these three NADCs in Tanzania have increased over the past 11 years, as has the prevalence of HIV positivity amongst these NADC patients. The current and possibly increasing burden of NADCs in Tanzania and other low- and middle-income countries with high HIV rates should be a focus for future cancer prevention and control and HIV therapy programs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN. 2012, [http://globocan.iarc.fr], v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN. 2012, [http://​globocan.​iarc.​fr], v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11
3.
go back to reference De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forma D, Plummer M: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, 13: 607-615. 10.1016/S1470-2045(12)70137-7.PubMedCrossRef De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forma D, Plummer M: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, 13: 607-615. 10.1016/S1470-2045(12)70137-7.PubMedCrossRef
6.
go back to reference Shiels M, Pfeiffer R, Gail M, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels A: Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011, 103: 753-762. 10.1093/jnci/djr076.PubMedPubMedCentralCrossRef Shiels M, Pfeiffer R, Gail M, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels A: Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011, 103: 753-762. 10.1093/jnci/djr076.PubMedPubMedCentralCrossRef
7.
go back to reference Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM: Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993–1995. Int J Cancer. 2000, 85: 54-59. 10.1002/(SICI)1097-0215(20000101)85:1<54::AID-IJC10>3.0.CO;2-D.PubMedCrossRef Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM: Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993–1995. Int J Cancer. 2000, 85: 54-59. 10.1002/(SICI)1097-0215(20000101)85:1<54::AID-IJC10>3.0.CO;2-D.PubMedCrossRef
8.
go back to reference Mbulaiteye S, Bhatia K, Adebamowo C, Sasco AJ: HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agents Cancer. 2011, 6: 16-10.1186/1750-9378-6-16.PubMedPubMedCentralCrossRef Mbulaiteye S, Bhatia K, Adebamowo C, Sasco AJ: HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agents Cancer. 2011, 6: 16-10.1186/1750-9378-6-16.PubMedPubMedCentralCrossRef
9.
go back to reference Koski L, Ngoma T, Mwaiselage J, Le L, Soliman AS: Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011). Int J STD AIDS. in press Koski L, Ngoma T, Mwaiselage J, Le L, Soliman AS: Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011). Int J STD AIDS. in press
10.
go back to reference Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Matthews WC, Hunt P, Eron JJ: Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence. AIDS. 2014, 28: 979-987. 10.1097/QAD.0000000000000167.PubMedPubMedCentralCrossRef Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Matthews WC, Hunt P, Eron JJ: Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence. AIDS. 2014, 28: 979-987. 10.1097/QAD.0000000000000167.PubMedPubMedCentralCrossRef
11.
go back to reference Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA: Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006, 118: 985-990. 10.1002/ijc.21443.PubMedCrossRef Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA: Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006, 118: 985-990. 10.1002/ijc.21443.PubMedCrossRef
12.
go back to reference Akarolo-Anthony SN, Dal Maso L, Igbinoba F, Mbulaiteye SM, Adebamowo CA: Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infect Agents Cancer. 2014, 9: 1-10.1186/1750-9378-9-1.PubMedPubMedCentralCrossRef Akarolo-Anthony SN, Dal Maso L, Igbinoba F, Mbulaiteye SM, Adebamowo CA: Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infect Agents Cancer. 2014, 9: 1-10.1186/1750-9378-9-1.PubMedPubMedCentralCrossRef
13.
go back to reference Stebbing J, Duru O, Bower M: Non-AIDS-defining cancer. Curr Opin Infect Dis. 2009, 22: 7-10. 10.1097/QCO.0b013e3283213080.PubMedCrossRef Stebbing J, Duru O, Bower M: Non-AIDS-defining cancer. Curr Opin Infect Dis. 2009, 22: 7-10. 10.1097/QCO.0b013e3283213080.PubMedCrossRef
14.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.PubMedCrossRef
15.
go back to reference Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D: Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003, 21: 3447-3453. 10.1200/JCO.2003.01.096.PubMedCrossRef Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D: Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003, 21: 3447-3453. 10.1200/JCO.2003.01.096.PubMedCrossRef
16.
go back to reference Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Moller H, Bower M: Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009, 27: 884-890. 10.1200/JCO.2008.19.6626.PubMedCrossRef Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Moller H, Bower M: Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009, 27: 884-890. 10.1200/JCO.2008.19.6626.PubMedCrossRef
18.
go back to reference Cancer incidence in five continents, vol X (electronic version). Edited by: Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Lyon: IARC, [http://ci5.iarc.fr] Cancer incidence in five continents, vol X (electronic version). Edited by: Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Lyon: IARC, [http://​ci5.​iarc.​fr]
19.
go back to reference Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ: Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006, 20: 1645-1654. 10.1097/01.aids.0000238411.75324.59.PubMedCrossRef Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ: Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006, 20: 1645-1654. 10.1097/01.aids.0000238411.75324.59.PubMedCrossRef
20.
go back to reference Frisch M, Biggar RJ, Engels EA, Goedert JJ, AIDS-Cancer Match Registry Study Group: Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001, 285: 1736-1745. 10.1001/jama.285.13.1736.PubMedCrossRef Frisch M, Biggar RJ, Engels EA, Goedert JJ, AIDS-Cancer Match Registry Study Group: Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001, 285: 1736-1745. 10.1001/jama.285.13.1736.PubMedCrossRef
21.
go back to reference Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA: AIDS-related cancer and severity of immunosuppression in persons with AIDS. JNCI. 2007, 99: 962-972. 10.1093/jnci/djm010.PubMedCrossRef Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA: AIDS-related cancer and severity of immunosuppression in persons with AIDS. JNCI. 2007, 99: 962-972. 10.1093/jnci/djm010.PubMedCrossRef
22.
go back to reference Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina RM, Castelli F, QuirosRoldan E: Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population of Northern Italy, 1999-2009. HIV Med. 2013, 14: 481-490. 10.1111/hiv.12034.PubMedCrossRef Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina RM, Castelli F, QuirosRoldan E: Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population of Northern Italy, 1999-2009. HIV Med. 2013, 14: 481-490. 10.1111/hiv.12034.PubMedCrossRef
23.
go back to reference Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, LeMabec T, Forstin MA, Renaudier P, N’Dom P, Malvy D, Dabis F: The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010, 5: e8621-10.1371/journal.pone.0008621.PubMedPubMedCentralCrossRef Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, LeMabec T, Forstin MA, Renaudier P, N’Dom P, Malvy D, Dabis F: The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010, 5: e8621-10.1371/journal.pone.0008621.PubMedPubMedCentralCrossRef
24.
go back to reference Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK, Wegner S: Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009, 23: 41-50. 10.1097/QAD.0b013e328317cc2d.PubMedPubMedCentralCrossRef Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK, Wegner S: Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009, 23: 41-50. 10.1097/QAD.0b013e328317cc2d.PubMedPubMedCentralCrossRef
25.
go back to reference Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF: Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005, 104: 1505-1511. 10.1002/cncr.21334.PubMedCrossRef Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF: Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005, 104: 1505-1511. 10.1002/cncr.21334.PubMedCrossRef
26.
go back to reference Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N: Characteristics of non-AIDS-defining malignancies in the HAART era: a clinic-epidemiological study. J Int AIDS Soc. 2011, 14: 16-10.1186/1758-2652-14-16.PubMedPubMedCentralCrossRef Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N: Characteristics of non-AIDS-defining malignancies in the HAART era: a clinic-epidemiological study. J Int AIDS Soc. 2011, 14: 16-10.1186/1758-2652-14-16.PubMedPubMedCentralCrossRef
27.
go back to reference Deeken JF, Tjen-A-Looi A, Rudek MA, Okuliar C, Young M, Little RF, Dezube BJ: The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012, 55: 1228-12335. 10.1093/cid/cis613.PubMedPubMedCentralCrossRef Deeken JF, Tjen-A-Looi A, Rudek MA, Okuliar C, Young M, Little RF, Dezube BJ: The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012, 55: 1228-12335. 10.1093/cid/cis613.PubMedPubMedCentralCrossRef
28.
go back to reference Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba , Herrington CS, Liomba G: Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Opthalmol. 1996, 80: 503-508. 10.1136/bjo.80.6.503.CrossRef Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba , Herrington CS, Liomba G: Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Opthalmol. 1996, 80: 503-508. 10.1136/bjo.80.6.503.CrossRef
29.
go back to reference Sun EC, Fears TR, Goedert JJ: Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev. 1997, 6: 73-77.PubMed Sun EC, Fears TR, Goedert JJ: Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev. 1997, 6: 73-77.PubMed
30.
go back to reference Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM: Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer. 2008, 122: 2590-2593. 10.1002/ijc.23384.PubMedCrossRef Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM: Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer. 2008, 122: 2590-2593. 10.1002/ijc.23384.PubMedCrossRef
31.
go back to reference Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000, 92: 1500-1510. 10.1093/jnci/92.18.1500.PubMedCrossRef Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000, 92: 1500-1510. 10.1093/jnci/92.18.1500.PubMedCrossRef
32.
go back to reference Cleator S, Fife K, Nelson M, Gazzard B, Phillips R, Bower M: Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer. 2000, 36: 754-758. 10.1016/S0959-8049(00)00009-5.PubMedCrossRef Cleator S, Fife K, Nelson M, Gazzard B, Phillips R, Bower M: Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer. 2000, 36: 754-758. 10.1016/S0959-8049(00)00009-5.PubMedCrossRef
33.
go back to reference Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R: The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1997, 37: 1101-1105. 10.1016/S0360-3016(96)00596-2.CrossRef Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R: The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1997, 37: 1101-1105. 10.1016/S0360-3016(96)00596-2.CrossRef
34.
go back to reference Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C: Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS. 2013, 27: 2933-2942. 10.1097/01.aids.0000433236.55937.cb.PubMedPubMedCentralCrossRef Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C: Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS. 2013, 27: 2933-2942. 10.1097/01.aids.0000433236.55937.cb.PubMedPubMedCentralCrossRef
Metadata
Title
The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin’s lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study
Authors
Clare Meernik
Amr S Soliman
Twalib Ngoma
Crispin Kahesa
Julius Mwaiselage
Sofia D Merajver
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2014
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/1750-9378-9-42

Other articles of this Issue 1/2014

Infectious Agents and Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine